Material Detail

Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

In real-life settings, two doses of mRNA vaccines proved to be effective against COVID-19 with the original virus, B.1.1.7 lineage and B.1.351/P.1 lineages.

Keyword:: COVID- 19 vaccine

Disciplines:

Health Sciences

Go to Material

Bookmark / Add to Course ePortfolio

Create a Learning Exercise

Add Accessibility Information

Rate

Add a Comment

Quality

Editor Reviews
User Rating
Comments
Learning Exercises
Bookmark Collections
Course ePortfolios
Accessibility Info

Report Broken Link
Report as Inappropriate

More about this material

Material Type:: Reference Material
Date Added to MERLOT:: August 17, 2021
Date Modified in MERLOT:: August 17, 2021
Author:: Unknown (Know the author?)
Submitter:: Mary Bemker
Primary Audience:: College Upper Division, Graduate School, Professional
Technical Format:: Website

Mobile Compatibility:: Not specified at this time
Technical Requirements:: Access via Google Chrome.
Language:: English
Cost Involved:: No
Source Code Available:: Yes
Accessibility Information Available:: Unknown
Creative Commons:: Unknown

Browse...

Disciplines with similar materials as Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

Health Sciences

People who viewed this also viewed

Other materials like Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France